Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV003383415 | SCV004091101 | uncertain significance | Inborn genetic diseases | 2023-08-21 | criteria provided, single submitter | clinical testing | The c.4621G>A (p.E1541K) alteration is located in exon 20 (coding exon 20) of the TUBGCP6 gene. This alteration results from a G to A substitution at nucleotide position 4621, causing the glutamic acid (E) at amino acid position 1541 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |